Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672953 | SCV000798112 | likely pathogenic | Argininosuccinate lyase deficiency | 2018-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000672953 | SCV004642449 | pathogenic | Argininosuccinate lyase deficiency | 2022-12-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ASL protein in which other variant(s) (p.Arg456Trp) have been determined to be pathogenic (PMID: 17326097, 19703900, 24166829, 26843370). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 32410394). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr437*) in the ASL gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 28 amino acid(s) of the ASL protein. |